From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
Crossref DOI link: https://doi.org/10.1038/s41418-020-00666-y
Published Online: 2020-12-17
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mak, Tak W.
Text and Data Mining valid from 2020-12-17
Version of Record valid from 2020-12-17
Article History
Received: 28 October 2020
Accepted: 28 October 2020
First Online: 17 December 2020
Compliance with ethical standards
:
: TWM is a co-founder of Agios Pharmaceuticals, Treadwell Therapeutics and Tcryption.